FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W114702829> ?p ?o ?g. }

• W114702829 abstract "BRCA mutations increase the risk for development of high-grade pelvic serous carcinomas. Tissue biomarkers distinguishing women at high-risk (HR) for ovarian cancer from those at low-risk (LR) may provide insights into tumor initiation pathways.A prospective study of 47 HR women (40% BRCA carriers) undergoing risk-reducing salpingo-oophorectomy and 48 LR controls undergoing salpingo-oophorectomy was performed. Ovarian/tubal tissues were harvested. Immunohistochemical analysis of candidate proteins CSF-1, CSF-1R, ErbB4 is presented, with scores separately analyzed in epithelium and stroma, in ampulla, fimbria, ovary, and ovarian endosalpingiosis (ES). Comparison was performed between HR and LR groups.Elevated levels of CSF-1 (p=0.005) or ErbB4 (p=0.005) in the ovarian epithelium, or ErbB4 (p=0.005) in the ovarian stroma, were significantly associated with both the HR status and carrying a BRCA mutation, as was nuclear ErbB4 staining. Ovarian ES, an entity which likely derives from the tubal mucosal epithelium, was also associated with HR (p=0.038) and BRCA mutation status (p=0.011). Among the BRCA carriers only, markers also found association when present in the tube as well as in ovarian ES (p < 0.05). ROCs were generated including in the regression model both CSF-1 and ErbB4 expression levels. A model including CSF-1 in ovarian epithelium, ErbB4 in ovarian stroma, and younger age achieves AUC=0.87 (73% sensitivity, 93% specificity) of detection of the HR status. In BRCA carriers, CSF-1 in ovarian epithelium alone achieves AUC=0.85.Our data suggest that elevated levels of CSF-1/ErbB4 in the adnexae correlate with HR/BRCA carrier status. CSF-1/CSF-1R signaling is active in ovarian cancer progression; our data suggests a role in its initiation. ErbB4, in particular nuclear ErbB4, may have a role in tumor initiation as well. Ovarian ES, an entity which may represent a latent precursor to low-grade pelvic serous carcinomas, was surprisingly associated with both HR status and the BRCA carrier cohort. In line with these findings, both ErbB4 and CSF-1R expression in ovarian ES correlated with carrying a BRCA mutation. This analysis, which needs to be validated, indirectly suggests a potential link between ovarian ES and the development of pelvic serous carcinoma in women who are BRCA mutation carriers." @default.
• W114702829 created "2016-06-24" @default.
• W114702829 creator A5031858099 @default.
• W114702829 creator A5032520795 @default.
• W114702829 creator A5043805914 @default.
• W114702829 creator A5055102047 @default.
• W114702829 creator A5060233974 @default.
• W114702829 creator A5072668492 @default.
• W114702829 creator A5080149644 @default.
• W114702829 date "2014-01-01" @default.
• W114702829 modified "2023-10-02" @default.
• W114702829 title "Biomarkers and endosalpingiosis in the ovarian and tubal microenvironment of women at high-risk for pelvic serous carcinoma." @default.
• W114702829 cites W1908622933 @default.
• W114702829 cites W1963718242 @default.
• W114702829 cites W1969505154 @default.
• W114702829 cites W1972807527 @default.
• W114702829 cites W1973253351 @default.
• W114702829 cites W1974113446 @default.
• W114702829 cites W1974223809 @default.
• W114702829 cites W1974756790 @default.
• W114702829 cites W1978421730 @default.
• W114702829 cites W1983194513 @default.
• W114702829 cites W1983253644 @default.
• W114702829 cites W1988656539 @default.
• W114702829 cites W1991152196 @default.
• W114702829 cites W1998901985 @default.
• W114702829 cites W1999182927 @default.
• W114702829 cites W2007245209 @default.
• W114702829 cites W2007269627 @default.
• W114702829 cites W2012377679 @default.
• W114702829 cites W2012975737 @default.
• W114702829 cites W2014013992 @default.
• W114702829 cites W2021312878 @default.
• W114702829 cites W2032080088 @default.
• W114702829 cites W2043492786 @default.
• W114702829 cites W2049897958 @default.
• W114702829 cites W2054443407 @default.
• W114702829 cites W2059814855 @default.
• W114702829 cites W2073883983 @default.
• W114702829 cites W2079681470 @default.
• W114702829 cites W2083957968 @default.
• W114702829 cites W2090855460 @default.
• W114702829 cites W2105156168 @default.
• W114702829 cites W2112369586 @default.
• W114702829 cites W2116788687 @default.
• W114702829 cites W2121172394 @default.
• W114702829 cites W2123415105 @default.
• W114702829 cites W2127250473 @default.
• W114702829 cites W2128104740 @default.
• W114702829 cites W2131261461 @default.
• W114702829 cites W2137504912 @default.
• W114702829 cites W2137849078 @default.
• W114702829 cites W2140601056 @default.
• W114702829 cites W2147281142 @default.
• W114702829 cites W2155294444 @default.
• W114702829 cites W2155587446 @default.
• W114702829 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3902233" @default.
• W114702829 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24482739" @default.
• W114702829 hasPublicationYear "2014" @default.
• W114702829 type Work @default.
• W114702829 sameAs 114702829 @default.
• W114702829 citedByCount "6" @default.
• W114702829 countsByYear W1147028292014 @default.
• W114702829 countsByYear W1147028292017 @default.
• W114702829 countsByYear W1147028292018 @default.
• W114702829 countsByYear W1147028292019 @default.
• W114702829 countsByYear W1147028292022 @default.
• W114702829 crossrefType "journal-article" @default.
• W114702829 hasAuthorship W114702829A5031858099 @default.
• W114702829 hasAuthorship W114702829A5032520795 @default.
• W114702829 hasAuthorship W114702829A5043805914 @default.
• W114702829 hasAuthorship W114702829A5055102047 @default.
• W114702829 hasAuthorship W114702829A5060233974 @default.
• W114702829 hasAuthorship W114702829A5072668492 @default.
• W114702829 hasAuthorship W114702829A5080149644 @default.
• W114702829 hasConcept C121608353 @default.
• W114702829 hasConcept C126322002 @default.
• W114702829 hasConcept C142724271 @default.
• W114702829 hasConcept C143998085 @default.
• W114702829 hasConcept C150173356 @default.
• W114702829 hasConcept C204232928 @default.
• W114702829 hasConcept C2775883341 @default.
• W114702829 hasConcept C2777632260 @default.
• W114702829 hasConcept C2778324911 @default.
• W114702829 hasConcept C2780194787 @default.
• W114702829 hasConcept C2780427987 @default.
• W114702829 hasConcept C2908988626 @default.
• W114702829 hasConcept C29456083 @default.
• W114702829 hasConcept C3019054536 @default.
• W114702829 hasConcept C52124034 @default.
• W114702829 hasConcept C529295009 @default.
• W114702829 hasConcept C71924100 @default.
• W114702829 hasConceptScore W114702829C121608353 @default.
• W114702829 hasConceptScore W114702829C126322002 @default.
• W114702829 hasConceptScore W114702829C142724271 @default.
• W114702829 hasConceptScore W114702829C143998085 @default.
• W114702829 hasConceptScore W114702829C150173356 @default.
• W114702829 hasConceptScore W114702829C204232928 @default.
• W114702829 hasConceptScore W114702829C2775883341 @default.
• W114702829 hasConceptScore W114702829C2777632260 @default.

• next